Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase subunit s, mitochondrial (ATP5S, also known as distal membrane arm assembly component 2 like, DMAC2L, or ATP synthase coupling factor B) is a protein subunit of the mitochondrial ATP synthase (Complex V) complex[1][3][5][9]. ATP synthase catalyzes the synthesis of ATP utilizing the proton gradient established across the mitochondrial inner membrane during oxidative phosphorylation[2][3][5][10]. The subunit s (factor B) is required for the proper energy transduction activity of the enzyme's Fo proton channel, contributing to the coupling of proton transport to ATP synthesis and overall structural assembly of the ATP synthase complex[3][8]. While ATP synthase dysfunction is implicated in multiple mitochondrial and degenerative diseases, specific roles of subunit s in pathology remain under investigation. Mutations or altered expression in ATP synthase structural subunits can impair mitochondrial energy production and may contribute to disorders of metabolism and potentially neurodegeneration[4][6][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase subunit s, mitochondrial (ATP5S).